Forthcoming Events SEE ALL
1st International Congress for the European Network Adult ADHD
The UK Adult ADHD Network (UKAAN) will host the 1st International Congress for the European Network Adult ADHD. The 2-day conference on the 22nd and 23rd September 2011 will be located in Central London in a beautiful venue overlooking the River Thames which will accommodate 462 delegates in a Lecture Theatre.
The conference will bring together internationally recognised experts in the diagnosis and treatment of ADHD across the lifespan and highlight basic science and clinical research that contributes to our current understanding of ADHD as a lifespan disorder. Clinical services for ADHD during the transition years from adolescence to adulthood and for those newly diagnosed as adults are developing rapidly throughout many parts of Europe. The conference will build on this growing expertise by providing a uniquely European perspective that highlights the full range of functional, cognitive and mental health impairments, the impact that ADHD has on adolescent and adult mental health and the contribution to adult psychopathology. This meeting will address important clinical and scientific questions relating to ADHD and will be relevant to anyone interested in the mental health of people from the adolescent years through to early, middle and later adult life.
ADHD is a common mental health disorder that starts during child development but frequently persists throughout adolescence and into the adult years. Common symptoms include inattention, distractibility, disorganisation, overactivity, restlessness, impulsiveness and mood instability; and these may lead to considerable clinical and psychosocial impairments. ADHD is often seen at a high rate in people with other significant clinical problems including substance abuse, unstable mood states, anxiety, depression, forensic cases and emerging or developed personality disorder.
Despite the considerable psychiatric morbidity associated with ADHD and the availability of effective pharmacological and non-pharmacological treatments, the disorder often goes unrecognised and untreated in people as they grow older. This leads to unnecessary distress to individuals, ineffective targeting of treatments, poor control over chronic mental health problems and the development of adult onset disorders later in life.
This meeting aims to raise the level of awareness and knowledge among health care professionals about people with ADHD as they grow older; and to provide a better understanding of the causal pathways involved in the persistence of the disorder and the development of important clinical comorbidities. The program will be delivered by prominent opinion leaders, clinical experts and internationally recognised investigators and is designed to cover key topics relevant to the diagnosis and treatment of ADHD during the critical period from adolescence to adulthood. The selection of speakers is particular important so that the audience can hear directly from the most experienced professionals working in this rapidly developing area of clinical psychiatry.
Professor Philip Asherson